Literature DB >> 15488954

Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings.

Johanna Assies1, Ieke Visser, Nancy A Nicolson, Teunis A Eggelte, Elisabeth M Wekking, Jochanan Huyser, Ritsaert Lieverse, Aart H Schene.   

Abstract

Major depression is often associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. In contrast to cortisol, dehydroepiandrosterone-sulfate (DHEA-S) has been less extensively studied in depressed patients. This study examined salivary morning and evening levels of cortisol and DHEA-S in 13 medicated, unipolar, non-psychotic depressed patients and 13 healthy volunteers. Diurnal declines in cortisol and DHEA-S levels were found in both depressed and control groups. In patients compared with controls, DHEA-S was significantly elevated, in conjunction with normal cortisol levels. Based on DHEA-S at 22:00 h only, 77% of the subjects were correctly classified in a discriminant analysis as depressed or control. When simultaneously entered in a multiple regression analysis, DHEA-S (morning and evening) and cortisol (evening only) predicted symptom severity in depressed patients. These preliminary results suggest that DHEA-S may be a more sensitive indicator of depression and symptom severity than cortisol in medicated but still clinically depressed patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488954     DOI: 10.1016/j.psychres.2004.05.016

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

1.  Measuring DHEA-S in saliva: time of day differences and positive correlations between two different types of collection methods.

Authors:  Courtney A Whetzel; Laura C Klein
Journal:  BMC Res Notes       Date:  2010-07-20

2.  Concurrent and prospective associations between HPA axis activity and depression symptoms in newlywed women.

Authors:  Fiona Ge; Paula R Pietromonaco; Casey J DeBuse; Sally I Powers; Douglas A Granger
Journal:  Psychoneuroendocrinology       Date:  2016-07-22       Impact factor: 4.905

3.  Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression.

Authors:  Christina M Hough; Daniel Lindqvist; Elissa S Epel; Molly St Denis; Victor I Reus; F Saverio Bersani; Rebecca Rosser; Laura Mahan; Heather M Burke; Owen M Wolkowitz; Synthia H Mellon
Journal:  Psychoneuroendocrinology       Date:  2016-12-05       Impact factor: 4.905

4.  Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study.

Authors:  Mary Frances Morrison; Ellen W Freeman; Hui Lin; Mary D Sammel
Journal:  Arch Womens Ment Health       Date:  2011-07-20       Impact factor: 3.633

Review 5.  The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.

Authors:  Erin M MacKenzie; John Odontiadis; Jean-Michel Le Mellédo; Trevor I Prior; Glen B I Baker
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

6.  Is the DHEAS/cortisol ratio a potential filter for non-operable constipated cases?

Authors:  A M El-Tawil
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

7.  Determination of cortisol and dehydroepiandrosterone levels in saliva for screening of periodontitis in older Japanese adults.

Authors:  Toshihiro Ansai; Inho Soh; Aiko Ishisaka; Akihiro Yoshida; Shuji Awano; Tomoko Hamasaki; Kazuo Sonoki; Yutaka Takata; Tadamichi Takehara
Journal:  Int J Dent       Date:  2010-02-01

8.  Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features.

Authors:  Zeynep Kotan; Emre Sarandöl; Emine Kırhan; Güven Ozkaya; Selcçuk Kırlı
Journal:  Ther Adv Psychopharmacol       Date:  2012-04

Review 9.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

10.  The assessment of stress, depression, and inflammation as a collective risk factor for periodontal diseases: a systematic review.

Authors:  Ann Decker; Houssam Askar; Mustafa Tattan; Russell Taichman; Hom-Lay Wang
Journal:  Clin Oral Investig       Date:  2019-11-01       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.